During the current study, we could not find any noticeable side effect of shallomin, while many of proposed protocols that are used for treatment of COVID-19 patients could cause serious side effects, such as the increased risk of bradycardia (Beyls et al., 2020), nausea, and breathing problems (Goldman et al., 2020), development of anemia (Praveen et al., 2020), the immunosuppression (King et al., 2020; Russell et al., 2020), and increased alanine aminotransferase during the treatment (Alattar et al., 2020). Here, GPT is linked to COVID-19.